Toxic neuronal apoptosis and modifications of tau and APP gene and protein expressions

Jacques Hugon, Françoise Esclaire, Mathieu Lesort, Glen Kisby, Peter Spencer

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The causes and the mechanisms of neuronal death in Alzheimer's disease are not elucidated, although some new insights have been proposed over the past years, including free-radical toxicity, beta-amyloid toxicity, excitotoxicity, and disturbed cellular calcium metabolism. Some authors have also pointed out that apoptosis could play a role in neuronal degeneration, but it is still largely debated. Here, we review some recent data linking the induction of experimental neuronal apoptosis in vitro and the molecular pathology of the tau protein and amyloid precursor protein (APP). In cultures exposed to mild glutamate toxicity, tau mRNA expression, not beta-actin, is enhanced in stressed neurons. The Guam cycad toxin metabolite methylazoxymethanol also produces an increase of tau gene transcription that exacerbates changes induced by glutamate. In serum-deprived cultures or glutamate-exposed cultures, neurons committed to apoptosis have a reduced tau gene expression, whereas resistant neurons display a stable or even augmented tau mRNA expression accompanied by a persistent tau phosphorylation near serine 202. In the same conditions, stressed neurons produce membrane blebbings strongly immunopositive for APP and putative amyloidogenic fragments that are subsequently released in the extracellular space. Experimental apoptosis in neurons can recapitulate tau and APP modifications that could be associated with a selective vulnerability and a progression of cellular degeneration along the neuronal network.

Original languageEnglish (US)
Pages (from-to)635-647
Number of pages13
JournalDrug Metabolism Reviews
Volume31
Issue number3
DOIs
StatePublished - 1999

Fingerprint

Amyloid beta-Protein Precursor
Poisons
Apoptosis
Gene Expression
Neurons
Glutamic Acid
Proteins
Guam
Amyloidogenic Proteins
tau Proteins
Messenger RNA
Protein Precursors
Molecular Pathology
Extracellular Space
Amyloid
Serine
Free Radicals
Actins
Alzheimer Disease
Phosphorylation

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Toxic neuronal apoptosis and modifications of tau and APP gene and protein expressions. / Hugon, Jacques; Esclaire, Françoise; Lesort, Mathieu; Kisby, Glen; Spencer, Peter.

In: Drug Metabolism Reviews, Vol. 31, No. 3, 1999, p. 635-647.

Research output: Contribution to journalArticle

Hugon, Jacques ; Esclaire, Françoise ; Lesort, Mathieu ; Kisby, Glen ; Spencer, Peter. / Toxic neuronal apoptosis and modifications of tau and APP gene and protein expressions. In: Drug Metabolism Reviews. 1999 ; Vol. 31, No. 3. pp. 635-647.
@article{d5b644bfeb7542f1b7ae9b16256bb12e,
title = "Toxic neuronal apoptosis and modifications of tau and APP gene and protein expressions",
abstract = "The causes and the mechanisms of neuronal death in Alzheimer's disease are not elucidated, although some new insights have been proposed over the past years, including free-radical toxicity, beta-amyloid toxicity, excitotoxicity, and disturbed cellular calcium metabolism. Some authors have also pointed out that apoptosis could play a role in neuronal degeneration, but it is still largely debated. Here, we review some recent data linking the induction of experimental neuronal apoptosis in vitro and the molecular pathology of the tau protein and amyloid precursor protein (APP). In cultures exposed to mild glutamate toxicity, tau mRNA expression, not beta-actin, is enhanced in stressed neurons. The Guam cycad toxin metabolite methylazoxymethanol also produces an increase of tau gene transcription that exacerbates changes induced by glutamate. In serum-deprived cultures or glutamate-exposed cultures, neurons committed to apoptosis have a reduced tau gene expression, whereas resistant neurons display a stable or even augmented tau mRNA expression accompanied by a persistent tau phosphorylation near serine 202. In the same conditions, stressed neurons produce membrane blebbings strongly immunopositive for APP and putative amyloidogenic fragments that are subsequently released in the extracellular space. Experimental apoptosis in neurons can recapitulate tau and APP modifications that could be associated with a selective vulnerability and a progression of cellular degeneration along the neuronal network.",
author = "Jacques Hugon and Fran{\cc}oise Esclaire and Mathieu Lesort and Glen Kisby and Peter Spencer",
year = "1999",
doi = "10.1081/DMR-100101939",
language = "English (US)",
volume = "31",
pages = "635--647",
journal = "Drug Metabolism Reviews",
issn = "0360-2532",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Toxic neuronal apoptosis and modifications of tau and APP gene and protein expressions

AU - Hugon, Jacques

AU - Esclaire, Françoise

AU - Lesort, Mathieu

AU - Kisby, Glen

AU - Spencer, Peter

PY - 1999

Y1 - 1999

N2 - The causes and the mechanisms of neuronal death in Alzheimer's disease are not elucidated, although some new insights have been proposed over the past years, including free-radical toxicity, beta-amyloid toxicity, excitotoxicity, and disturbed cellular calcium metabolism. Some authors have also pointed out that apoptosis could play a role in neuronal degeneration, but it is still largely debated. Here, we review some recent data linking the induction of experimental neuronal apoptosis in vitro and the molecular pathology of the tau protein and amyloid precursor protein (APP). In cultures exposed to mild glutamate toxicity, tau mRNA expression, not beta-actin, is enhanced in stressed neurons. The Guam cycad toxin metabolite methylazoxymethanol also produces an increase of tau gene transcription that exacerbates changes induced by glutamate. In serum-deprived cultures or glutamate-exposed cultures, neurons committed to apoptosis have a reduced tau gene expression, whereas resistant neurons display a stable or even augmented tau mRNA expression accompanied by a persistent tau phosphorylation near serine 202. In the same conditions, stressed neurons produce membrane blebbings strongly immunopositive for APP and putative amyloidogenic fragments that are subsequently released in the extracellular space. Experimental apoptosis in neurons can recapitulate tau and APP modifications that could be associated with a selective vulnerability and a progression of cellular degeneration along the neuronal network.

AB - The causes and the mechanisms of neuronal death in Alzheimer's disease are not elucidated, although some new insights have been proposed over the past years, including free-radical toxicity, beta-amyloid toxicity, excitotoxicity, and disturbed cellular calcium metabolism. Some authors have also pointed out that apoptosis could play a role in neuronal degeneration, but it is still largely debated. Here, we review some recent data linking the induction of experimental neuronal apoptosis in vitro and the molecular pathology of the tau protein and amyloid precursor protein (APP). In cultures exposed to mild glutamate toxicity, tau mRNA expression, not beta-actin, is enhanced in stressed neurons. The Guam cycad toxin metabolite methylazoxymethanol also produces an increase of tau gene transcription that exacerbates changes induced by glutamate. In serum-deprived cultures or glutamate-exposed cultures, neurons committed to apoptosis have a reduced tau gene expression, whereas resistant neurons display a stable or even augmented tau mRNA expression accompanied by a persistent tau phosphorylation near serine 202. In the same conditions, stressed neurons produce membrane blebbings strongly immunopositive for APP and putative amyloidogenic fragments that are subsequently released in the extracellular space. Experimental apoptosis in neurons can recapitulate tau and APP modifications that could be associated with a selective vulnerability and a progression of cellular degeneration along the neuronal network.

UR - http://www.scopus.com/inward/record.url?scp=0032811459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032811459&partnerID=8YFLogxK

U2 - 10.1081/DMR-100101939

DO - 10.1081/DMR-100101939

M3 - Article

C2 - 10461544

AN - SCOPUS:0032811459

VL - 31

SP - 635

EP - 647

JO - Drug Metabolism Reviews

JF - Drug Metabolism Reviews

SN - 0360-2532

IS - 3

ER -